ScoreWhy is Procter & Gamble Health Ltd ?
1
High Management Efficiency with a high ROE of 36.14%
2
The company is Net-Debt Free
3
Poor long term growth as Net Sales has grown by an annual rate of 8.78% and Operating profit at 14.53% over the last 5 years
4
Positive results in Mar 26
- ROCE(HY) Highest at 65.27%
- PBDIT(Q) Highest at Rs 135.59 cr.
- PBT LESS OI(Q) Highest at Rs 129.21 cr.
5
With ROE of 52.8, it has a Very Expensive valuation with a 16.7 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 6.79%, its profits have risen by 22.9% ; the PEG ratio of the company is 1.4
6
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -0.94% over the previous quarter and collectively hold 19.87% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to P & G Health Ltd should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is P & G Health Ltd for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
P & G Health Ltd
6.79%
0.28
24.62%
Sensex
-5.98%
-0.45
13.24%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.78%
EBIT Growth (5y)
14.53%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
1.80
Tax Ratio
27.33%
Dividend Payout Ratio
88.52%
Pledged Shares
0
Institutional Holding
19.87%
ROCE (avg)
87.52%
ROE (avg)
36.14%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
32
Industry P/E
34
Price to Book Value
16.72
EV to EBIT
23.28
EV to EBITDA
22.08
EV to Capital Employed
29.68
EV to Sales
7.16
PEG Ratio
1.39
Dividend Yield
3.28%
ROCE (Latest)
115.53%
ROE (Latest)
52.75%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
ROCE(HY)
Highest at 65.27%
PBDIT(Q)
Highest at Rs 135.59 cr.
PBT LESS OI(Q)
Highest at Rs 129.21 cr.
PAT(Q)
Highest at Rs 94.60 cr.
EPS(Q)
Highest at Rs 56.99
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for P & G Health Ltd
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 129.21 cr has Grown at 71.32%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 94.60 cr has Grown at 54.6%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 135.59 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 129.21 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 94.60 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 56.99
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
